Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine.
Éva RákócziGusztáv MagócsSára KovácsBéla NagyGabriella SzűcsZoltán SzekaneczPublished in: Diagnostics (Basel, Switzerland) (2023)
To address the concept that basic BBIBP-CorV vaccination is not as effective as BNT162b, we analyzed the effect of heterologous vaccination with BNT162b2. Our results suggest that BNT162b2 can successfully boost the effects of two-dose BBIBP-CorV vaccination.
Keyphrases